Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Molecular and Cell Biology in Endometriosis and Endometrial Cancer"
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: 31 May 2023 | Viewed by 5369
Special Issue Editor
Interests: uterine disease; endometriosis; endometrial cancer; molecular pathology
Special Issue Information
The endometrium has been a subject of intense research in a variety of clinical settings because of its importance in the reproductive process and its roles in women’s health. Under the exposure of different risk factors in a woman’s lifetime, normal endometrial tissue can give rise to multiple pathologic conditions, including endometriosis and endometrial cancer. Although the methods for diagnosis of endometriosis and endometrial cancer are well developed in modern gynecology, the underlying etiology and pathophysiologic changes remain largely unclear.
The focus of this Biomolecules Special Issue is on the molecular and cellular mechanisms of endometriosis and endometrial cancer. Areas to be covered in this Special Issue may include but are not limited to the molecular pathophysiology of endometriosis and endometrial cancer, genetic and epigenetic changes in endometriosis, endometrial stem/progenitor cells, the molecular basis for a specific therapeutic approach, molecular biomarkers for endometriosis and endometrial cancer.
We expect that this Special Issue will provide novel information on the abovementioned topics and be of interest to scientists and clinicians already working on or seeking to understand the molecular and cell biology of endometriosis and endometrial cancer. Therefore, contributions by experts in the field, in the form of original research papers and reviews are most welcome.
Dr. Jacqueline F. Donoghue
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- endometrial cancer
- ovarian cancer
- molecular basis of endometriosis and endometrial cancer
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Ovarian cancer in women with endometriosis: what are the implications for women with an intact endometrioma planning for a future pregnancy?
Authors: Johnny S. Younis
Affiliation: Baruch Padeh Medical Center, Poriya and Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.